The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Long-term Outcomes Among Older Patients Following Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation for Advanced Hematologic Malignancies
Open accessAbstract
CONTEXT: A minimally toxic nonmyeloablative regimen was developed for allogeneic hematopoietic cell transplantation (HCT) to treat patients with advanced hematologic malignancies who are older or have comorbid conditions. OBJECTIVE: To describe outcomes of patients 60 years or older after receiving minimally toxic nonmyeloablative allogeneic HCT. DESIGN, SETTING, AND PARTICIPANTS: From 1998 to 2008, 372 patients aged 60 to 75 years were enrolled in prospective clinical HCT trials at 18 collaborating institutions using conditioning with low-dose total body irradiation alone or combined with fludarabine, 90 mg/m(2), before related (n = 184) or unrelated (n = 188) donor transplants. Postgrafting immunosuppression included mycophenolate mofetil and a calcineurin inhibitor. MAIN OUTCOME MEASURES: Overall and progression-free survival were estimated by Kaplan-Meier method. Cumulative incidence estimates were calculated for acute and chronic graft-vs-host disease, toxicities, achievement of full donor chimerism, complete remission, relapse, and nonrelapse mortality. Hazard ratios (HRs) were estimated from Cox regression models. RESULTS: Overall, 5-year cumulative incidences of nonrelapse mortality and relapse were 27% (95% CI, 22%-32%) and 41% (95% CI, 36%-46%), respectively, leading to 5-year overall and progression-free survival of 35% (95% CI, 30%-40%) and 32% (95% CI, 27%-37%), respectively. These outcomes were not statistically significantly different when stratified by age groups. Furthermore, increasing age was not associated with increases in acute or chronic graft-vs-host disease or organ toxicities. In multivariate models, HCT-specific comorbidity index scores of 1 to 2 (HR, 1.58 [95% CI, 1.08-2.31]) and 3 or greater (HR, 1.97 [95% CI, 1.38-2.80]) were associated with worse survival compared with an HCT-specific comorbidity index score of 0 (P = .003 overall). Similarly, standard relapse risk (HR, 1.67 [95% CI, 1.10-2.54]) and high relapse risk (HR, 2.22 [95% CI, 1.43-3.43]) were associated with worse survival compared with low relapse risk (P < .001 overall). CONCLUSION: Among patients aged 60 to 75 years treated with nonmyeloablative allogeneic HCT, 5-year overall and progression-free survivals were 35% and 32%, respectively.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1994 Consensus Conference on Acute GVHD Grading.
Przepiorka, D., Weisdorf, D., Martin, P., Hg, K., Beatty, P., Hows, J., & Thomas, E. D. (1995) · PubMed · Cited by 5,037
Sorror, M. L., Maris, M. B., Storb, R., Baron, F., Sandmaier, B. M., Maloney, D. G., & Storer, B. (2005) · Blood · doi:10.1182/blood-2005-05-2004 · Cited by 2,969
Self-citationGooley, T. A., Leisenring, W., Crowley, J., & Storer, B. E. (1999) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19990330)18:6<695::aid-sim60>3.0.co;2-o · Cited by 2,688
Self-citationFuture of Cancer Incidence in the United States: Burdens Upon an Aging, Changing Nation
Smith, B. D., Smith, G. L., Hurria, A., Hortobagyi, G. N., & Buchholz, T. A. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.8983 · Cited by 1,721
Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
Gooley, T. A., Chien, J. W., Pergam, S. A., Hingorani, S., Sorror, M. L., Boeckh, M., Martin, P. J., Sandmaier, B. M., Marr, K. A., Appelbaum, F. R., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1004383 · Cited by 1,493
Self-citationMcSweeney, P. A., Niederwieser, D., Shizuru, J. A., Sandmaier, B. M., Molina, A. J., Maloney, D. G., Chauncey, T. R., Gooley, T. A., Hegenbart, U., Nash, R. A., et al. (2001) · Blood · doi:10.1182/blood.v97.11.3390 · Cited by 1,389
Self-citationAge and acute myeloid leukemia
Appelbaum, F. R., Gundacker, H., Head, D. R., Slovak, M. L., Willman, C. L., Godwin, J. E., Anderson, J. E., & Petersdorf, S. H. (2006) · Blood · doi:10.1182/blood-2005-09-3724 · Cited by 1,350
Keating, M. J., Flinn, I., Jain, V., Binet, J.-L., Hillmen, P., Byrd, J., Albitar, M., Brettman, L., Santabarbara, P., Wacker, B., et al. (2002) · Blood · doi:10.1182/blood.v99.10.3554 · Cited by 948
The aging of the immune system
Weiskopf, D., Weinberger, B., & Grubeck-Loebenstein, B. (2009) · Transplant International · doi:10.1111/j.1432-2277.2009.00927.x · Cited by 908
Efficacy of Lenalidomide in Myelodysplastic Syndromes
List, A., Kurtin, S., Roe, D. J., Buresh, A., Mahadevan, D., Fuchs, D., Rimsza, L., Heaton, R., Knight, R., & Zeldis, J. B. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041668 · Cited by 880
Hematopoietic Cell Transplantation
Forman, S. J., & Nakamura, R. (2015) · Blackwell Science Ltd eBooks · Cited by 659
Gratwohl, A., Hermans, J., Goldman, J., Arcese, W., Carreras, E., Devergie, A., Frassoni, F., Gahrton, G., Kolb, H., Niederwieser, D., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)03030-x · Cited by 646
Self-citationMcClune, B. L., Weisdorf, D. J., Pedersen, T. L., Tunes da Silva, G., Tallman, M. S., Sierra, J., DiPersio, J., Keating, A., Gale, R. P., George, B., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.4821 · Cited by 487
Self-citationPetersdorf, E. W., Gooley, T. A., Anasetti, C., Martin, P. J., Smith, A. G., Mickelson, E. M., Woolfrey, A. E., & Hansen, J. A. (1998) · Blood · doi:10.1182/blood.v92.10.3515 · Cited by 480
Association of Comorbidity with Disability in Older Women
Fried, L. P., Bandeen-Roche, K., Kasper, J. D., & Guralnik, J. M. (1999) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00124-3 · Cited by 454
Kantarjian, H., Ravandi, F., O'Brien, S., Cortes, J., Faderl, S., Garcia-Manero, G., Jabbour, E., Wierda, W., Kadia, T., Pierce, S., et al. (2010) · Blood · doi:10.1182/blood-2010-03-276485 · Cited by 403
Maris, M. B., Niederwieser, D., Sandmaier, B. M., Storer, B., Stuart, M., Maloney, D., Petersdorf, E., McSweeney, P., Pulsipher, M., Woolfrey, A., et al. (2003) · Blood · doi:10.1182/blood-2003-02-0482 · Cited by 336
Self-citationBaron, F., Maris, M. B., Sandmaier, B. M., Storer, B. E., Sorror, M., Diaconescu, R., Woolfrey, A. E., Chauncey, T. R., Flowers, M. E. D., Mielcarek, M., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.136 · Cited by 333
Self-citationSorror, M. L., Giralt, S., Sandmaier, B. M., De Lima, M., Shahjahan, M., Maloney, D. G., Deeg, H. J., Appelbaum, F. R., Storer, B., & Storb, R. (2007) · Blood · doi:10.1182/blood-2007-06-096966 · Cited by 326
Self-citationSorror, M. L., Maris, M. B., Storb, R. F., Baron, F., Sandmaier, B. M., Maloney, D. G., & Barry, S. E. (2005) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2004.12.067 · Cited by 323
Self-citationLim, Z., Brand, R., Martino, R., van Biezen, A., Finke, J., Bacigalupo, A., Beelen, D., Devergie, A., Alessandrino, E., Willemze, R., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.21.8073 · Cited by 299
Self-citationDuration of immunosuppressive treatment for chronic graft-versus-host disease
Stewart, B. L., Storer, B., Storek, J., Deeg, H. J., Storb, R., Hansen, J. A., Appelbaum, F. R., Carpenter, P. A., Sanders, J. E., Kiem, H.-P., et al. (2004) · Blood · doi:10.1182/blood-2004-01-0200 · Cited by 281
Self-citationKahl, C., Storer, B. E., Sandmaier, B. M., Mielcarek, M., Maris, M. B., Blume, K. G., Niederwieser, D., Chauncey, T. R., Forman, S. J., Agura, E., et al. (2007) · Blood · doi:10.1182/blood-2007-03-078592 · Cited by 163
Self-citationVose, J. M., Bierman, P., Anderson, J., Kessinger, A., Pierson, J. L., Nelson, J., Frappier, B., Schmit-Pokorny, K. A., Weisenburger, D. D., & Armitage, J. O. (1992) · Blood · doi:10.1182/blood.v80.8.2142.2142 · Cited by 147
Böttcher, S., Ritgen, M., Pott, C., Brüggemann, M., Raff, T., Stilgenbauer, S., Döhner, H., Dreger, P., & Kneba, M. (2004) · Leukemia · doi:10.1038/sj.leu.2403478 · Cited by 99
Immunologic recovery after hematopoietic cell transplantation with nonmyeloablative conditioning
Maris, M. B., Boeckh, M., Storer, B. E., Dawson, M. A., White, K., Keng, M. K., Sandmaier, B. M., Maloney, D. G., Storb, R. F., & Storek, J. (2003) · Experimental Hematology · doi:10.1016/s0301-472x(03)00201-7 · Cited by 98
Self-citationCastermans, E., Hannon, M., Dutrieux, J., Humblet‐Baron, S., Seidel, L., Cheynier, R., Willems, E., Gothot, A., Vanbellinghen, J.-F., Geenen, V. G., et al. (2010) · Haematologica · doi:10.3324/haematol.2010.029702 · Cited by 87
Self-citationSullivan, K. M. (2003) · Wiley eBooks · doi:10.1002/9780470987070.ch50 · Cited by 83
Rotta, M., Storer, B. E., Storb, R. F., Martin, P. J., Heimfeld, S., Peffer, A., Maloney, D. G., Deeg, H. J., Sandmaier, B. M., Appelbaum, F. R., et al. (2009) · Blood · doi:10.1182/blood-2009-08-240358 · Cited by 53
Self-citationShinohara, M., & Nakamura, S. (1998) · Journal of Japanese Society for Oral Mucous Membrane · doi:10.6014/jjomm1995.4.1 · Cited by 8
Cited by
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Conditioning regimens for hematopoietic cell transplantation: one size does not fit all
Gyurkocza, B., & Sandmaier, B. M. (2014) · Blood · doi:10.1182/blood-2014-02-514778 · Cited by 614
Self-citationTreating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors
Kochenderfer, J. N., & Rosenberg, S. A. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.46 · Cited by 451
Sorror, M. L., Storb, R. F., Sandmaier, B. M., Maziarz, R. T., Pulsipher, M. A., Maris, M. B., Bhatia, S., Ostronoff, F., Deeg, H. J., Syrjala, K. L., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.8157 · Cited by 423
Self-citationHematopoietic stem cell transplantation for patients with AML in first complete remission
Cornelissen, J. J., & Blaise, D. (2016) · Blood · doi:10.1182/blood-2015-07-604546 · Cited by 346
Metadata
- Authors
- Sorror, M. L., Sandmaier, B. M., Storer, B. E., Franke, G. N., Laport, G. G., Chauncey, T. R., Agura, E., Maziarz, R. T., Langston, A., Hari, P., Pulsipher, M. A., Bethge, W., Sahebi, F., Bruno, B., Maris, M. B., Yeager, A., Petersen, F. B., Vindeløv, L., McSweeney, P. A., Hübel, K., Mielcarek, M., Georges, G. E., Niederwieser, D., Blume, K. G., Maloney, D. G., & Storb, R.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2011-11-02
- Volume
- 306
- Issue
- 17
- Pages
- 1874
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2065738117
- Cited by
- 320
- References
- 30
- FWCI
- 13.39
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.